Our Pricing

Understanding Wegovy Maintenance Dose Private Prescriptions in the UK

Obtaining a wegovy maintenance dose private prescription has become increasingly accessible for UK patients seeking sustained weight management support. The maintenance dose of 2.4mg weekly represents the therapeutic endpoint of the Wegovy titration schedule, where maximum efficacy is achieved for long-term weight loss. At Cured Pharmacy, our UK-registered prescribers provide comprehensive assessments to determine suitability for Wegovy maintenance therapy, with transparent pricing from £69.00 and discreet next-day delivery across the United Kingdom.

What Is the Wegovy Maintenance Dose for Private Prescription Patients?

The Wegovy maintenance dose private prescription refers to the final therapeutic dose of 2.4mg semaglutide administered once weekly. This dose is reached after a carefully structured titration schedule that begins at 0.25mg and increases gradually over 16-20 weeks to minimise gastrointestinal side effects whilst optimising weight loss outcomes [1]. Clinical data from the STEP trials demonstrated that patients reaching and maintaining the 2.4mg dose achieved an average weight reduction of 14.9% from baseline over 68 weeks [2].

When you obtain a Wegovy maintenance dose private prescription through Cured Pharmacy, our UK-registered clinical team ensures you've completed the appropriate dose escalation and are medically suitable for ongoing treatment at this therapeutic level. The maintenance dose is designed for long-term use, with continuation dependent on individual response, tolerability, and ongoing clinical assessment by a qualified prescriber. Patients typically remain on the 2.4mg maintenance dose indefinitely whilst weight management goals are being met and the medication remains well-tolerated.

Wegovy Dose Escalation Schedule to Maintenance

The pathway to obtaining a Wegovy maintenance dose private prescription follows a structured titration protocol: 0.25mg weekly for 4 weeks, 0.5mg weekly for 4 weeks, 1.0mg weekly for 4 weeks, 1.7mg weekly for 4 weeks, and finally 2.4mg weekly as the maintenance dose [1]. This gradual escalation is essential for minimising common side effects such as nausea, vomiting, and diarrhoea. Some patients may require extended time at intermediate doses if tolerability issues arise, and this individualised approach is supported by our prescribing team at Cured Pharmacy. Once the maintenance dose is established, patients continue with 2.4mg weekly injections, with regular clinical reviews to monitor efficacy, safety, and ongoing suitability for treatment.

Cost of Wegovy Maintenance Dose Private Prescription at Cured Pharmacy

Cured Pharmacy offers the Wegovy maintenance dose private prescription from £69.00 per pen, representing competitive UK pricing for this licensed weight management treatment. This transparent pricing structure is provided upfront, before any clinical consultation, ensuring patients can make informed decisions about their treatment costs. New patients can Save £20 off their first order using the code Weightlossnew, further reducing the initial investment in their weight loss journey.

The cost of a Wegovy maintenance dose private prescription reflects the ongoing nature of weight management therapy. Each 2.4mg pen provides four weeks of treatment (one injection per week), meaning the monthly cost remains consistent and predictable. Unlike some providers who charge consultation fees separately, Cured Pharmacy includes a free online clinical assessment with every order, conducted by UK-registered prescribers. All prices include VAT, and we guarantee the lowest prices for genuine UK-licensed Wegovy in the United Kingdom.

How to Get a Wegovy Maintenance Dose Private Prescription Online

Obtaining a Wegovy maintenance dose private prescription through Cured Pharmacy is a straightforward process designed for convenience and clinical safety. Patients complete a comprehensive online medical questionnaire that takes under three minutes, covering medical history, current medications, weight management goals, and previous experience with GLP-1 receptor agonists. This information is reviewed by our UK-registered prescribers, including our superintendent pharmacist Tarun Kumar (GPhC 2233073), who assess suitability for the maintenance dose.

If approved, your Wegovy maintenance dose private prescription is issued electronically and dispensed from our GPhC-registered pharmacy (9012511). Orders are dispatched with discreet packaging and next-day delivery options across the UK. Patients already established on Wegovy at lower doses can request to progress to the maintenance dose, whilst those new to semaglutide therapy will be prescribed the appropriate starting dose with clear guidance on titration. Ongoing prescriptions for the maintenance dose require periodic clinical reviews to ensure continued safety and efficacy, all managed conveniently through our online platform.

Clinical Assessment for Wegovy Maintenance Dose Prescriptions

Every Wegovy maintenance dose private prescription issued by Cured Pharmacy follows MHRA and NICE guidelines for obesity management. Our prescribers assess body mass index (BMI), weight-related comorbidities, contraindications, and previous response to weight loss interventions. Patients must typically have a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related condition such as type 2 diabetes, hypertension, or dyslipidaemia [3]. The clinical assessment also screens for contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease. This thorough evaluation ensures that only appropriate patients receive a Wegovy maintenance dose private prescription, maximising safety and therapeutic outcomes.

Wegovy Maintenance Dose Private Prescription: Expected Results and Duration

Patients maintaining a Wegovy maintenance dose private prescription can expect sustained weight loss when combined with lifestyle modifications including dietary changes and increased physical activity. In the STEP 1 trial, participants receiving 2.4mg semaglutide weekly achieved a mean weight reduction of 14.9% from baseline at week 68, compared to 2.4% with placebo [2]. Importantly, weight loss continues progressively during the first year of treatment, with the maintenance dose providing the optimal therapeutic effect for long-term weight management.

The duration of Wegovy maintenance dose private prescription therapy varies by individual response and clinical goals. Many patients continue treatment for 12-24 months or longer, with ongoing prescriber oversight to monitor efficacy and safety. Clinical guidelines suggest that treatment should be discontinued if patients do not achieve at least 5% weight loss after 12 weeks at the maintenance dose, or if significant side effects develop [3]. At Cured Pharmacy, our prescribers conduct regular reviews to assess whether continuation on the maintenance dose remains clinically appropriate, ensuring optimal outcomes for each patient's weight management journey.

Side Effects and Safety of Wegovy Maintenance Dose Private Prescription

The Wegovy maintenance dose private prescription at 2.4mg weekly is generally well-tolerated when reached through proper dose titration, though some patients experience ongoing side effects. The most common adverse effects are gastrointestinal, including nausea (44% of patients), diarrhoea (30%), vomiting (24%), and constipation (24%) in clinical trials [2]. These symptoms are typically mild to moderate and often diminish over time as the body adapts to the medication. The gradual dose escalation protocol significantly reduces the severity and incidence of these effects compared to starting at higher doses.

More serious but rare risks associated with a Wegovy maintenance dose private prescription include pancreatitis, gallbladder disease, acute kidney injury, and hypoglycaemia in patients taking concomitant glucose-lowering medications [1]. Patients are advised to seek immediate medical attention if they experience severe abdominal pain, persistent vomiting, or signs of allergic reaction. Our prescribers at Cured Pharmacy provide comprehensive safety information with every Wegovy maintenance dose private prescription, including guidance on recognising warning signs and when to seek medical review. Regular clinical monitoring ensures any emerging safety concerns are identified and managed promptly.

Managing Side Effects on Wegovy Maintenance Dose

Patients holding a Wegovy maintenance dose private prescription can employ several strategies to minimise side effects and improve tolerability. Eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and injecting at a consistent time each week can reduce gastrointestinal symptoms. If nausea or vomiting becomes problematic at the 2.4mg maintenance dose, prescribers may consider temporarily reducing to 1.7mg before re-attempting escalation, or prescribing anti-nausea medications for short-term symptom management. Our clinical team at Cured Pharmacy provides personalised advice for managing side effects, ensuring patients can continue benefiting from their Wegovy maintenance dose private prescription whilst maintaining quality of life and treatment adherence.

Wegovy Maintenance Dose Private Prescription vs NHS Availability

Access to a Wegovy maintenance dose private prescription offers significant advantages in availability and convenience compared to NHS provision. Whilst Wegovy is approved by NICE for NHS use in England, access remains severely restricted due to supply constraints and strict eligibility criteria requiring participation in specialist weight management services [4]. NHS patients often face waiting times of many months or are unable to access treatment at all in their area. Private prescriptions through Cured Pharmacy bypass these barriers, providing immediate access subject to clinical suitability assessment.

The cost of a Wegovy maintenance dose private prescription at £69.00 per month represents an investment in timely, convenient weight management care. Private provision includes benefits such as online consultations, discreet home delivery, flexible appointment times, and direct access to prescribers for ongoing support. Whilst NHS provision would be free at the point of use where available, the practical reality of limited access makes private prescriptions the only viable option for most UK patients seeking Wegovy maintenance dose therapy. Our transparent pricing at Cured Pharmacy ensures patients understand the full cost commitment before beginning treatment.

Long-Term Value of Private Wegovy Maintenance Dose Prescriptions

Investing in a Wegovy maintenance dose private prescription delivers long-term health and economic value beyond the monthly medication cost. Sustained weight loss of 10-15% can significantly reduce the risk and severity of obesity-related conditions including type 2 diabetes, cardiovascular disease, sleep apnoea, and osteoarthritis [3]. Many patients experience improvements in these comorbidities, potentially reducing the need for other medications and healthcare interventions. When viewed as part of a comprehensive health investment, the cost of a Wegovy maintenance dose private prescription becomes a proactive measure that may prevent more expensive medical complications in the future, whilst delivering immediate quality of life improvements through effective weight management.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 15 August 2026]
2. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. NICE. [accessed 15 August 2026]
4. NHS England. (2023). Clinical Commissioning Policy: Treatment of severe and complex obesity with very low energy diets and specialist obesity services. NHS England. [accessed 15 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.